Shire announces third quarter 2009 financial results News-Medical.net We have also continued to grow VYVANSE's market share which is now 13.4%, benefiting from both the 'back to school' season and strong 10% ADHD market growth ... and more » |
Shire Continues to Deliver Excellent Growth From Core Products SunHerald.com (press release) We have also continued to grow VYVANSE's market share which is now 13.4%, benefiting from both the 'back to school' season and strong 10% ADHD market growth ... |
REG-Shire plc: 3rd Quarter Results Reuters We have also continued to grow vyvanse's market share which is now 13.4%, benefiting from both the `back to school' season and strong 10% ADHD market growth ... and more » |
Back to school: Nonmedication options to help ADHD Examiner.com And so starts another year with his ADHD. Some people would say, "Isn't this boy on his meds?" The answer is no. His parents tried several different types ... |
Back to school: Nonmedication options to help ADHD Examiner.com And so starts another year with his ADHD. Some people would say, "Isn't this boy on his meds?" The answer is no. His parents tried several different types ... |